Skip to content

Septerna, Inc. SEPN Other Commercial Liabilities

Other Commercial Liabilities at other companies

Amgen logo
AmgenAMGN
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Arrowhead Research logo
Arrowhead ResearchARWR
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s other commercial liabilities?
Septerna, Inc. (SEPN) reported other commercial liabilities of $8.63M in Q1 2026.
How has Septerna, Inc.'s other commercial liabilities changed year-over-year?
Septerna, Inc.'s other commercial liabilities increased by 98.3% year-over-year, from $4.35M to $8.63M.
What is the long-term trend for Septerna, Inc.'s other commercial liabilities?
Over 2 years (2023 to 2025), Septerna, Inc.'s other commercial liabilities has grown at a 68.7% compound annual growth rate (CAGR), from $4.28M to $12.17M.